about
Advances in sickle cell therapies in the hydroxyurea eraComorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES ProjectSickle cell disease: an opportunity for palliative care across the life span.Sickle cell disease: a neglected chronic disease of increasing global health importancePlanning for the economic and career impact of a sickle cell anemia programAttitudes toward clinical trials among patients with sickle cell disease.A new agenda and a new alliance.Survival of children with sickle cell disease.Mortality of New York children with sickle cell disease identified through newborn screening.Sickle Cell Trait from a Metabolic, Renal, and Vascular Perspective: Linking History, Knowledge, and Health.Patterns of mortality in sickle cell disease in the United Kingdom.Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.Milestones in the history of hemoglobin research (in memory of professor Titus H.J. Huisman).Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease.Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.Pediatric sickle cell disease: past successes and future challenges.Challenges and resilience in the lives of adults with sickle cell disease.Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care.
P2860
Q28088552-EA156B79-4CBF-4362-9053-B93ED652157CQ33552132-A928C304-8F81-48E3-BFC3-47028ABA1692Q34100978-F8D6B045-3AD5-49DC-98C1-1FC465EF2574Q34852524-7BCFAD37-9DD4-4BD4-8691-AFD468BA91DBQ35099738-34C875BD-3995-43C7-B399-1547D739C315Q35287718-073F706D-2B1D-4461-A37F-A992AE49514EQ35542447-39EF7249-3E80-4C66-9BDD-D0DEA6CF1AF4Q35690101-68FD91E4-0C62-40B8-81CE-2313D7DDFC3FQ35856569-03B9C5A4-9FF8-4536-9195-E12D0243A8E9Q35994946-BEAC52E3-82E8-4886-971C-E8FB7A0F841DQ37141786-24511CB0-8814-4DDE-AF9D-DEFB8E4C8087Q37677221-EA87A72E-BAE1-4862-AED6-E20F50CD204FQ37935768-8A96D362-05BE-4996-AFE3-4A6171574A18Q38257400-0F82C2E8-2AFF-4EE5-A553-6D1F9C485832Q38627797-BEEACF6F-1B5E-417F-998E-9D5A720B07CFQ38814652-DF1A5955-C4A0-4B24-AAD7-9561613C7FB3Q39270632-D09BB089-CD0C-4D37-83A5-271E5E3477CDQ45005129-75861485-D13A-4A3A-8E52-744056222911
P2860
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Health care priority and sickle cell anemia.
@en
Health care priority and sickle cell anemia.
@nl
type
label
Health care priority and sickle cell anemia.
@en
Health care priority and sickle cell anemia.
@nl
prefLabel
Health care priority and sickle cell anemia.
@en
Health care priority and sickle cell anemia.
@nl
P1476
Health care priority and sickle cell anemia.
@en
P2093
P304
P356
10.1001/JAMA.1970.03180040039008
P407
P577
1970-10-01T00:00:00Z